HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keiichirou Morimura Selected Research

Nitrosomethylurethane

10/2002Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keiichirou Morimura Research Topics

Disease

33Neoplasms (Cancer)
03/2013 - 01/2002
32Carcinogenesis
03/2013 - 01/2002
12Carcinoma (Carcinomatosis)
11/2010 - 07/2002
8Hyperplasia
11/2006 - 01/2002
6Cystitis
11/2009 - 04/2003
6Body Weight (Weight, Body)
12/2007 - 05/2002
5Colitis
07/2008 - 02/2007
4Adenocarcinoma
07/2010 - 01/2002
4Inflammation (Inflammations)
11/2009 - 11/2007
4Adenoma (Adenomas)
04/2008 - 01/2002
4Liver Cell Adenoma (Hepatocellular Adenoma)
04/2007 - 11/2004
4Aberrant Crypt Foci
01/2005 - 09/2002
3Colorectal Neoplasms (Colorectal Cancer)
07/2010 - 12/2004
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2008 - 02/2007
3Fibrosis (Cirrhosis)
05/2008 - 01/2005
3Hepatocellular Carcinoma (Hepatoma)
04/2008 - 11/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2010 - 08/2008
2Esophageal Neoplasms (Esophageal Cancer)
07/2010 - 11/2002
2Kidney Neoplasms (Kidney Cancer)
12/2009 - 12/2004
2Stomach Neoplasms (Stomach Cancer)
05/2009 - 03/2008
2Gastritis
05/2009 - 03/2008
2Infections
08/2008 - 05/2004
2Fibroadenoma
04/2008 - 12/2004
2Liver Neoplasms (Liver Cancer)
06/2006 - 07/2002
2Liver Diseases (Liver Disease)
04/2006 - 05/2005
2Liver Cirrhosis (Hepatic Cirrhosis)
05/2005 - 01/2005
2Esophageal Squamous Cell Carcinoma
12/2004 - 11/2002
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2004 - 01/2003
1Schistosomiasis (Bilharziasis)
08/2008
1Hypoxia (Hypoxemia)
06/2008

Drug/Important Bio-Agent (IBA)

16CarcinogensIBA
03/2013 - 07/2002
88-Hydroxy-2'-DeoxyguanosineIBA
08/2008 - 02/2002
6Diethylnitrosamine (N-Nitrosodiethylamine)IBA
03/2013 - 05/2002
6Glutathione Transferase (Glutathione S-Transferase)IBA
04/2008 - 08/2003
5ArsenicIBA
06/2006 - 01/2002
4nitrosobenzylmethylamineIBA
03/2013 - 05/2002
4Ethanol (Ethyl Alcohol)IBA
03/2013 - 05/2002
4Thioacetamide (Thioacetamid)IBA
05/2008 - 01/2005
4Cacodylic Acid (Cacodylate)IBA
06/2006 - 01/2002
4Messenger RNA (mRNA)IBA
11/2005 - 08/2003
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2013 - 02/2002
3TransferasesIBA
11/2010 - 07/2010
3EnzymesIBA
11/2010 - 05/2002
3Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
11/2010 - 07/2010
3Pharmaceutical PreparationsIBA
07/2010 - 12/2004
3NF-kappa B (NF-kB)IBA
11/2009 - 04/2003
3DNA (Deoxyribonucleic Acid)IBA
08/2008 - 08/2004
3Dextran SulfateIBA
07/2008 - 02/2008
3LigandsIBA
11/2007 - 05/2006
3Proliferating Cell Nuclear Antigen (PCNA)IBA
04/2006 - 09/2002
3Proteins (Proteins, Gene)FDA Link
11/2005 - 08/2003
3monomethylarsonic acid (MSMA)IBA
08/2004 - 07/2002
3Cyclin D1IBA
10/2002 - 08/2002
2Environmental CarcinogensIBA
03/2013 - 07/2002
2Cytochrome P-450 CYP2E1 (CYP2E1)IBA
03/2013 - 12/2007
2Fluorouracil (Carac)FDA LinkGeneric
11/2010 - 07/2010
2p38 Mitogen-Activated Protein KinasesIBA
11/2009 - 04/2003
2Growth Factor ReceptorsIBA
11/2009 - 11/2006
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2008 - 01/2006
2CytokinesIBA
02/2008 - 02/2007
2PPAR gammaIBA
11/2007 - 02/2007
2PPAR alphaIBA
06/2007 - 05/2006
2pirinixic acidIBA
06/2007 - 11/2004
2Biological ProductsIBA
05/2007 - 12/2003
2OligonucleotidesIBA
04/2007 - 07/2002
2ErbB Receptors (EGF Receptor)IBA
11/2006 - 06/2006
2Transforming Growth Factor alpha (TGF-alpha)IBA
06/2006 - 04/2006
2Peroxisome ProliferatorsIBA
05/2006 - 11/2004
2Phenobarbital (Luminal)FDA Link
04/2006 - 02/2002
2ParaffinIBA
01/2006 - 04/2004
2beta CateninIBA
01/2006 - 01/2006
2Cytochrome P-450 CYP2B1 (PROD)IBA
11/2005 - 08/2003
22- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
07/2005 - 07/2002
2CollagenIBA
05/2005 - 01/2005
24- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamideIBA
01/2005 - 12/2003
21,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
01/2005 - 12/2003
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2005 - 12/2003
2Dimenhydrinate (DMH)FDA LinkGeneric
01/2005 - 12/2003
2trimethyloxamine (trimethylamine N-oxide)IBA
08/2004 - 07/2002
2Arsenicals (Arsenic Compounds)IBA
08/2004 - 07/2002
2trimethylarsine oxideIBA
08/2004 - 07/2002
2Methylnitronitrosoguanidine (MNNG)IBA
05/2004 - 10/2002
2NitrosaminesIBA
03/2004 - 05/2002
2Hydroxyl RadicalIBA
08/2003 - 02/2002
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2003 - 08/2002
1steroid hormone 7-alpha-hydroxylaseIBA
03/2013
1Thymidylate SynthaseIBA
11/2010
1N-ethyl-N-hydroxyethylnitrosamineIBA
12/2009
1potassium bromateIBA
12/2009
1CesiumIBA
11/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2008
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
08/2008
1Genetic Markers (Genetic Marker)IBA
08/2008
1MucinsIBA
07/2008
1Hepatocyte Nuclear FactorsIBA
07/2008
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
06/2008
1Von Hippel-Lindau Tumor Suppressor ProteinIBA
06/2008

Therapy/Procedure

2Gastrectomy
05/2009 - 03/2008
2Lymph Node Excision (Lymph Node Dissection)
05/2009 - 11/2002
2Oral Administration
01/2006 - 01/2002